| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Jan 25 | ACN Accenture | Class A ordinary shares | Payment of exercise | Dispose F | No | No | 383.32 | 419 | 160.61 k | 6,436 |
| 15 Nov 24 | ACN Accenture | Class A ordinary shares | Grant | Acquire A | No | No | 0 | 4 | 0.00 | 6,855 |
| 15 Aug 24 | ACN Accenture | Class A ordinary shares | Grant | Acquire A | No | No | 0 | 4 | 0.00 | 6,851 |
| 15 May 24 | ACN Accenture | Class A ordinary shares | Grant | Acquire A | No | No | 0 | 4 | 0.00 | 6,847 |
| 26 Apr 24 | ABT Abbott Laboratories | Common shares without par value | Grant | Acquire A | No | No | 0 | 1,866 | 0.00 | 37,089 |
| 26 Apr 24 | ABT Abbott Laboratories | Option Common Shares | Grant | Acquire A | No | No | 107.14 | 6,850 | 733.91 k | 6,850 |
